Cabazitaxel for the Treatment of mCRPC: Data From the PROSELICA and FIRSTANA Trials

Neal Shore, MD, FACS, discusses data from the PROSELICA and FIRSTANA trials investigating cabazitaxel for the treatment of mCRPC, including a look at the post-hoc analyses of PROSELICA.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.